Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 3:53 AM
Ignite Modification Date: 2025-12-26 @ 2:42 AM
NCT ID: NCT01175902
Description: None
Frequency Threshold: 0
Time Frame: During the 12 weeks study period
Study: NCT01175902
Study Brief: Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension Glaucoma
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Dorzolamide/Timolol Patients on Dorzolamide/Timolol eyedrops dorzolamide/timolol fixed combination: Cosopt eyedrop, 2 times a day latanoprost: compare with Cosopt one time a day None None 0 44 0 44 View
Latanoprost Patients on Latanoprost eyedrops dorzolamide/timolol fixed combination: Cosopt eyedrop, 2 times a day latanoprost: compare with Cosopt one time a day None None 0 44 0 44 View
Serious Events(If Any):
Other Events(If Any):